STAAR Surgical (STAA) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
STAAR Surgical Reports First Quarter 2017 Results
May 3, 2017 4:01 PM EDTMONROVIA, Calif., May 3, 2017 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye today reported financial results for the first quarter ended March 31, 2017.
First Quarter 2017 Overview
Quarterly Net Sales of $20.4 Million Up 6% from the Prior Year Quarter ICL Sales Up 16% and Units Up 20% from the Prior Year Quarter IOL Sales Down 9% and Units Flat from the Prior Year Quarter Gross Margin Improved to 71.6% of Sales from 67.4% of Sales... More